Biophysical characterization of dynamic structures of immunoglobulin G

S Yanaka, R Yogo, K Kato - Biophysical Reviews, 2020 - Springer
S Yanaka, R Yogo, K Kato
Biophysical Reviews, 2020Springer
Immunoglobulin G (IgG) is a major antibody and functions as a hub linking specific antigen
binding and recruitment of effector molecules typified by Fcγ receptors (FcγRs). These
activities are associated primarily with interactions involving its Fab and Fc sites,
respectively. An IgG molecule is characterized by a multiple domain modular structure with
conserved N-glycosylation in Fc. The molecule displays significant freedom in internal
motion on various spatiotemporal scales. The consequent conformational flexibility and …
Abstract
Immunoglobulin G (IgG) is a major antibody and functions as a hub linking specific antigen binding and recruitment of effector molecules typified by Fcγ receptors (FcγRs). These activities are associated primarily with interactions involving its Fab and Fc sites, respectively. An IgG molecule is characterized by a multiple domain modular structure with conserved N-glycosylation in Fc. The molecule displays significant freedom in internal motion on various spatiotemporal scales. The consequent conformational flexibility and plasticity of IgG glycoproteins are functionally significant and potentially important factors for design and engineering of antibodies with enhanced functionality. In this article, experimental and computational approaches are outlined for characterizing the conformational dynamics of IgG molecules in solution. In particular, the importance of integration of these approaches is highlighted, as illustrated by dynamic intramolecular interactions between the pair of N-glycans and their proximal amino acid residues in Fc. These interactions can critically affect effector functions mediated by human IgG1 and FcγRIII. Further improvements in individual biophysical techniques and their integration will advance understanding of dynamic behaviors of antibodies in physiological and pathological conditions. Such understanding will provide opportunities for engineering antibodies through controlling allosteric networks in IgG molecules.
Springer